Lidocaine HCl Injection recall (Eugia US LLC)
DrugClass IIIOngoing
Summary: Eugia US LLC is recalling Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02. Reason: Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan.
What is being recalled
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02
Why
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
How serious is it
Class III is the least serious level: using or being exposed to this product is not likely to cause health problems, but it breaks FDA rules.
Where it was sold
US Nationwide.
How to tell if yours is affected
Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029
What to do
Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.
Recall facts
| Recall number | D-0552-2026 |
| Category | Drug |
| Agency | U.S. Food and Drug Administration (FDA) |
| Severity | Class III |
| Status | Ongoing |
| Recall started | May 18, 2026 |
| Reported | June 10, 2026 |
| Company | Eugia US LLC |
| Company location | East Windsor, NJ, United States |
| Initiated by | Voluntary: Firm initiated |
| Quantity | 168,300 vials |
More recalls from Eugia US LLC · all drug recalls · recalls from May 2026